Land: Irland
Sprog: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Xylometazoline hydrochloride; Dexpanthenol
KRKA, d.d., Novo mesto
R01AB; R01AB06
Xylometazoline hydrochloride; Dexpanthenol
0.5 mg/50 milligram(s)
Nasal spray, solution
Product subject to prescription which may be renewed (B)
Sympathomimetics, combinations excl. corticosteroids; xylometazoline
Not marketed
2016-12-02
PACKAGE LEAFLET: INFORMATION FOR THE USER SEPTANAZAL FOR CHILDREN 0.5 MG/50 MG IN 1 ML NASAL SPRAY, SOLUTION xylometazoline hydrochloride/dexpanthenol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if your child do not feel better or if your child feels worse after 3 days. WHAT IS IN THIS LEAFLET 1. What Septanazal for children is and what it is used for 2. What you need to know before you use Septanazal for children 3. How to use Septanazal for children 4. Possible side effects 5. How to store Septanazal for children 6. Contents of the pack and other information 1. WHAT SEPTANAZAL FOR CHILDREN IS AND WHAT IT IS USED FOR Septanazal for children nasal spray contains xylometazoline hydrochloride and dexpanthenol. Xylometazoline hydrochloride rapidly constricts blood vessels in the nasal mucous membrane and reduces the swelling of the nasal mucous membrane and mucus secretion. In this way the feeling of a blocked nose is reduced. Dexpanthenol is a derivative of the vitamin pantothenic acid, which promotes healing and protects the nasal mucous membrane. Septanazal for children is used: - for reducing the swelling of the nasal mucous membrane in nasal mucous membrane inflammation (rhinitis) and to promote healing of mucous membrane lesions, - for relief in non-allergic nasal mucous membrane inflammation (vasomotor rhinitis). - Upon medical advice only, Septanazal for children is also used for the treatment of worsened breathing through the nose after nasal surgery. This medicine is intended for use in children aged 2 to 6 years. 2. WHAT YOU NEED TO KN Læs hele dokumentet
Health Products Regulatory Authority 18 July 2023 CRN00DMJS Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Septanazal for children 0.5 mg/ 50 mg in 1 ml nasal spray solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of nasal spray, solution, contains 0.5 mg xylometazoline hydrochloride and 50 mg dexpanthenol. One actuation contains 0.1 ml of nasal spray, solution, containing 0.05 mg xylometazoline hydrochloride and 5.0 mg dexpanthenol. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Nasal spray, solution (Nasal spray). Clear, colourless liquid solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Septanazal for children is indicated: - for reducing the swelling of the nasal mucosa in rhinitis and as supportive treatment for healing mucous membrane lesions, - for relief in vasomotor rhinitis (rhinitis vasomotorica), - for the treatment of nasal respiratory obstruction after nasal surgery. Septanazal for children is indicated for children aged 2 to 6 years. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Paediatric population_ CHILDREN 2 TO 6 YEARS OF AGE The usual dose of Septanazal for children in children aged 2 to 6 years is one spray into each nostril up to 3 times a day, as needed. Septanazal for children is contraindicated in children under 2 years of age (see section 4.3). Method of administration Nasal use. First the protective cap should be removed from the sprayer. Before the first use or if the spray has not been used for a long period of time, the spray head should be pressed 5 times until a fine spray appears. Health Products Regulatory Authority 18 July 2023 CRN00DMJS Page 2 of 6 The sprayer tip should be inserted as upright as possible into one nostril and the spray head should be pressed once. Patient should gently inhale through the nose while spraying. If necessary, the procedure should be repeated for the other nostril. After each use, the sprayer tip should be wiped with a paper tissue and the cap placed back on the spr Læs hele dokumentet